13F filing recap · Q4 2022

What did Giverny Capital buy in Q4 2022?

Reported stock-position changes between this filing and the previous one.

Stock value

$1.62B

Positions

Estimated turnover

8.2%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

MBCMasterbrand, Inc.$6.80Mreported value+900.1K shares VOOVanguard Index Funds$2.42Mreported value+6.9K shares UNHUnitedHealth Group Incorporated$918.8Kreported value+1.7K shares BNBrookfield Corporation$523.8Kreported value+16.6K shares JJacobs Solutions Inc.$494.0Kreported value+4.1K shares

Increased positions

AMEAmetek, Inc.$119.22Mreported value+6.5K shares+0.8%FIVEFive Below, Inc.$109.37Mreported value+2.0K shares+0.3%SCHWSchwab Charles Corp$103.48Mreported value+14.3K shares+1.2%KMXCarmax, Inc.$87.40Mreported value+207.8K shares

Reduced positions

BRK.BBerkshire Hathaway Inc$142.53Mreported value-1.4K shares-0.3%MKLMarkel Group Inc.$107.19Mreported value-793 shares-1.0%KEYSKeysight Technologies, Inc.$79.20Mreported value-2.3K shares-0.5%GOOGAlphabet Inc.$78.70Mreported value-6.1K shares

Exited positions

BAMBrookfield Corporation$681.0Kprior reported value-16.6K shares-100.0%LLYEli Lilly & Co$140.0Kprior reported value-432 shares-100.0%